Cryo-Cell International, Inc. (CCEL)
Market Cap | 56.89M |
Revenue (ttm) | 31.37M |
Net Income (ttm) | -9.73M |
Shares Out | 8.10M |
EPS (ttm) | -1.16 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,437 |
Open | 7.21 |
Previous Close | 7.43 |
Day's Range | 6.90 - 7.21 |
52-Week Range | 3.67 - 9.50 |
Beta | 0.56 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Jul 12, 2024 |
About CCEL
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufacture... [Read more]
Financial Performance
Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/k/t/press11-2372515.jpg)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced ...
![](https://cdn.snapi.dev/images/v1/p/r/press16-2340453.jpg)
Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company” or “Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 19...
![](https://cdn.snapi.dev/images/v1/p/r/press15-2300505.jpg)
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...
![](https://cdn.snapi.dev/images/v1/p/r/press18-2101801.jpg)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, anno...
![](https://cdn.snapi.dev/images/v1/p/r/press20-1972635.jpg)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...
![](https://cdn.snapi.dev/images/v1/p/r/press2-1848655.jpg)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced ...
![](https://cdn.snapi.dev/images/v1/d/s/press18-1775746.jpg)
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022
OLDSMAR, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in ...
![](https://cdn.snapi.dev/images/v1/9/j/press3-1583725.jpg)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results
OLDSMAR, Fla., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem ce...
![](https://cdn.snapi.dev/images/v1/q/w/press3-1514845.jpg)
Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend
OLDSMAR, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store ste...
![](https://cdn.snapi.dev/images/v1/l/y/press8-1509760.jpg)
Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange
OLDSMAR, Fla., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”, the “Company”), the world's first private cord blood bank to separat...
![](https://cdn.snapi.dev/images/v1/p/f/press14-1447590.jpg)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results
OLDSMAR, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...
![](https://cdn.snapi.dev/images/v1/w/y/press14-1319769.jpg)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results
OLDSMAR, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...
![](https://cdn.snapi.dev/images/v1/j/r/press11-1281262.jpg)
Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service
OLDSMAR, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ...
![](https://cdn.snapi.dev/images/v1/d/j/press16-1270948.jpg)
Cryo-Cell Shares Its 2021 Annual Letter to Shareholders
OLDSMAR, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ...
![](https://cdn.snapi.dev/images/v1/t/m/press10-1245152.jpg)
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021
OLDSMAR, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...
![](https://cdn.snapi.dev/images/v1/o/p/press16-1071674.jpg)
Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials
OLDSMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...
![](https://cdn.snapi.dev/images/v1/q/p/press17-1051949.jpg)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...
![](https://cdn.snapi.dev/images/v1/1/n/press3-1014988.jpg)
Cryo-Cell International Announces Changes To Its Board of Directors
MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy...
![](https://cdn.snapi.dev/images/v1/o/7/press17-985612.jpg)
Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market
Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company's Common Stock Has Been Approved For Listing On The Na...
![](https://cdn.snapi.dev/images/v1/p/z/press7-974167.jpg)
Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area.
![](https://cdn.snapi.dev/images/v1/r/7/conf8-960005.jpg)
Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021
Oldsmar, Florida--(Newsfile Corp. - August 11, 2021) - Cryo-Cell International (OTC Pink: CCEL) today announced that David Portnoy, Chairman of the board and Co-CEO will be attending the Q3 Virtual In...
![](https://cdn.snapi.dev/images/v1/x/v/conf3-959479.jpg)
Cryo-Cell International to Present at the Q3 Virtual Investor Summit
MIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International announces that Chairman of the Board and Co-CEO, David Portnoy, will be presenting at the Q3 Virtual Investor Summit on August 18 th , ...
![](https://cdn.snapi.dev/images/v1/c/l/press20-910517.jpg)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results
OLDSMAR, Fla., July 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem...
![](https://cdn.snapi.dev/images/v1/s/n/press1-814333.jpg)
Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials
MIAMI, May 10, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell's Medical Director, Dr. Joanne Kurtzberg and her research team at The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine are...
![](https://cdn.snapi.dev/images/v1/p/r/press18-767136.jpg)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results
OLDSMAR, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...